Sorted By:

Relevance


Watch: Biomarkers in drug development with Dr. Bernie Zeiher

PhRMA  |  Blog Post

Biomarkers are powerful tools which are used by medical professionals in many ways, including in the diagnosis of disease, monitoring how a disease is progressing and, if a treatment is given, how the body is responding.
http://catalyst.phrma.org/watch-biomarkers-in-drug-development-with-dr.-bernie-zeiher-0-0

A Delicate Balance - Pharmaceutical Innovation and Access

PhRMA  |  Codes & Guidelines

Chief Medical Officer and Executive Vice President, Science and Regulatory Affairs, PhRMA published in The New England Journal of Medicine.
https://www.phrma.org

How much are hospitals marking up the price of medicines? The answer may surprise you.

PhRMA  |  Blog Post

View the analysis infographics here. 
http://catalyst.phrma.org/how-much-are-hospitals-marking-up-the-price-of-medicines-the-answer-may-surprise-you

Biopharmaceutical industry policies aim to increase access to clinical trial data

PhRMA  |  Blog Post

The biopharmaceutical industry believes that disclosure of clinical trial results and appropriate sharing of clinical trial data is in the best interests of patients, clinicians, medical research and the biopharmaceutical industry. 
http://catalyst.phrma.org/biopharmaceutical-industry-policies-aim-to-increase-access-to-clinical-trial-data

Research in Georgia

PhRMA  |  Research In Your Backyard

News and World Report, Emory University School of Medical ranked 21st and the Medical College of Georgia ranked 71st among this year’s top 100 research-oriented medical schools in the United States.
https://www.phrma.org/research-in-your-backyard/research-in-georgia

Guest Post: Advancing oncology research through clinical trials

PhRMA  |  Blog Post

., medical oncologist and vice president, Global Clinical Oncology, Merck Research Laboratories.
http://catalyst.phrma.org/guest-post-advancing-oncology-research-through-clinical-trials

Joaquin Duato Named PhRMA Board Chairman

PhRMA  |  Press Release

At a time of extraordinary advances in medical discovery, I look forward to leading PhRMA and ensuring patients have access to the treatments of today and the cures of tomorrow.” 
https://www.phrma.org/press-release/joaquin-duato-named-phrma-board-chairman

India’s IP Policies: Still Much Room for Improvement

PhRMA  |  Blog Post

-India relationship, both our patients and our economies stand to reap the benefits.
http://catalyst.phrma.org/indias-ip-policies-still-much-room-for-improvement

Medicines in Development for Arthritis 2014 Report

PhRMA  |  Report

“Biopharmaceutical research companies are working with partners across the ecosystem to bring treatments to help ease the pain and suffering caused by arthritis, but challenges remain,” said PhRMA President and CEO John J.
https://www.phrma.org/report/medicines-in-development-for-arthritis-2014-report

Increasing Competition Within Therapeutic Categories

Chartpack  |  From Our Network

The time a medicine is the only drug available in its therapeutic class has declined from a median of more than 10 years in the 1970s to less than 2 years by 1998.
http://chartpack.phrma.org/biophrma-chartpack/research-and-development/increasing-competition-within-therapeutic-categories

Medicare Monday: Medicare Part B and biosimilars

PhRMA  |  Blog Post

With the first U.S. biosimilar approved in March of 2015, the pathway created by the Biologics Price Competition and Innovation Act to bring biosimilars to market for U.S. patients has become a reality. 
http://catalyst.phrma.org/medicare-monday-medicare-part-b-and-biosimilars

PhRMA Statement on Comments to CMS Regarding Proposed Part D Rule and RFI Exploring Pass-Through Rebates to Seniors at Point of Sale

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.Innovation.org www.
https://www.phrma.org/press-release/phrma-statement-on-comments-to-cms-regarding-proposed-part-d-rule-and-rfi-exploring-pass-through-rebates-to-seniors-at-point-of-sale

PhRMA's Dr. Chin talks about Diabetes

PhRMA  |  Video

PhRMA Executive VP and Chief Medical Officer William Chin M.D. talks about new and exciting therapies for diabetes.
https://www.phrma.org/video/phrma-s-dr-chin-talks-about-diabetes

Helping Patients Drives America's Biopharmaceutical Researchers and Scientists

PhRMA  |  Video

Michael Rosenblatt, chief medical officer at Merck, along with countless others in the health care ecosystem, are working tirelessly each and every day to help address the remaining unmet medical needs for patients.
https://www.phrma.org/video/helping-patients-drives-america-s-biopharmaceutical-researchers-and-scientists

Senior Director - Public Affairs

PhRMA  |  PhRMA Career

We offer traditional (medical, dental, vision, flexible spending, life, AD&D, LTD, STD, LTC) and enhanced benefits such as parental leave, health advocate service, back-up childcare, commuting and financial & estate planning benefits.
https://www.phrma.org

PDUFA

PhRMA  |  From PhRMA

Ensures that FDA can hire and retain a strong scientific and medical workforce to advance its public health mission.
https://www.phrma.org/advocacy/research-development/pdufa

Medicine Safety

PhRMA  |  From PhRMA

Learn more about the key medical safety issues facing our industry today.
https://www.phrma.org/advocacy/safety

Science of Hope: Incorporating the Patient Perspective

PhRMA  |  Video

Al Sandrock, chief medical officer at Biogen, shares his experiences working in the biopharmaceutical industry, and how first-hand accounts from patients motivate him every day.
https://www.phrma.org/video/science-of-hope-incorporating-the-patient-perspective

Medicines in Development for Diabetes 2016 Report

PhRMA  |  Report


https://www.phrma.org/report/medicines-in-development-for-diabetes2

Government-imposed price controls threaten innovation and access

PhRMA  |  Blog Post

It’s not just India either—South Korea has taken similar steps.
http://catalyst.phrma.org/government-imposed-price-controls-threaten-innovation-and-access

Biopharmaceutical Industry Pipeline Panel Discussion

PhRMA  |  Video

John Lechleiter, PhD, Chairman, President, and Chief Executive Officer of Eli Lilly and Company and the Chairman of PhRMA joins PhRMA President and CEO John Castellani and Genia Long, Managing Principal, Analysis Group for this Webinar to discuss the future of biopharmaceutical innovation. 
https://www.phrma.org/video/biopharmaceutical-industry-pipeline-panel-discussion

New report highlights need to speed patent examination

PhRMA  |  Blog Post

For example, countries such as Korea are strengthening commitments to patent processing and currently experiencing pendency of 2.8 years compared to 6.3 years in India.
http://catalyst.phrma.org/new-report-highlights-need-to-speed-patent-examination

What they are saying: Rising deductibles and out-of-pocket costs in health insurance plans

PhRMA  |  Blog Post

” – .nytimes.com/2016/01/06/upshot/lost-jobs-houses-savings-even-insured-often-face-crushing-medical-debt.html?
http://catalyst.phrma.org/what-they-are-saying-rising-deductibles-and-out-of-pocket-costs-in-health-insurance-plans

FDA Modernization

PhRMA  |  From PhRMA

Solutions Reduce the Generic Backlog and Incentivize Competition Where Needed A generic drug enters the market at the end of an innovative medication’s lifecycle.
https://www.phrma.org/advocacy/research-development/fda-modernization

Curbing Health Care Costs

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/curbing-health-care-costs

You have reviewed the first 150 results out of 1047. Each page contains 25 results. You're on page 6.

prev 1 2 3 4 5 6 next